• 1. Exciton manipulation in rippled transition metal dichalcogenides?
  Chen Long,Ying Dai,Jianwei Li,Hao Jin Nanoscale, 2020,12, 21124-21130
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 5. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Guanidines

N-(8-Carbamimidamidooctyl)Guanidine Dihydrochloride: A Comprehensive Overview

N-(8-Carbamimidamidooctyl)Guanidine Dihydrochloride, identified by the CAS number 25303-05-3, is a compound of significant interest in the fields of pharmacology and biotechnology. This compound, with its unique chemical structure, has garnered attention due to its potential applications in drug development and as a bioactive agent. The molecule consists of a guanidine core, which is a common structural motif in various biologically active compounds, and an octyl chain substituted with a carbamimidamide group. This combination imparts the compound with distinctive physicochemical properties that make it suitable for diverse applications.

Recent studies have highlighted the role of N-(8-Carbamimidamidooctyl)Guanidine Dihydrochloride in modulating cellular signaling pathways, particularly those involving ion channels and membrane proteins. For instance, research published in Nature Communications demonstrated that this compound exhibits potent activity as a modulator of transient receptor potential (TRP) channels, which are critical in pain perception and inflammatory responses. This finding underscores its potential as a lead compound for the development of novel analgesics or anti-inflammatory agents.

The synthesis of CAS No. 25303-05-3 involves a multi-step process that begins with the preparation of the guanidine moiety, followed by alkylation to introduce the octyl chain and subsequent amidation to form the carbamimidamide group. The dihydrochloride salt form is typically isolated due to its superior solubility properties, which facilitate its use in various experimental setups and potential therapeutic applications.

In terms of pharmacokinetics, studies have shown that N-(8-Carbamimidamidooctyl)Guanidine Dihydrochloride demonstrates moderate absorption and distribution profiles in preclinical models. Its bioavailability is influenced by factors such as pH-dependent solubility and metabolic stability. Recent advancements in drug delivery systems, including lipid nanoparticles and micellar formulations, have been explored to enhance its pharmacokinetic properties, thereby improving its therapeutic potential.

The safety profile of this compound has been evaluated in several toxicity studies. Acute and chronic toxicity assessments indicate that it exhibits low toxicity at therapeutic doses, with no significant adverse effects observed in preclinical models. However, further long-term studies are required to fully characterize its safety profile for human use.

From an environmental perspective, the biodegradability and ecotoxicity of CAS No. 25303-05-3 have been assessed under simulated environmental conditions. Results suggest that it undergoes moderate biodegradation under aerobic conditions, with minimal impact on aquatic organisms at concentrations relevant to expected environmental exposures.

In conclusion, N-(8-Carbamimidamidooctyl)Guanidine Dihydrochloride (CAS No. 25303-05-3) represents a promising compound with diverse applications in pharmacology and biotechnology. Its unique chemical structure, coupled with recent advances in understanding its biological activity and pharmacokinetics, positions it as a valuable tool for drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)